Zonisamide



Zonisamide





(zoh niss’ ah myde)

Zonegran

PREGNANCY CATEGORY C


Drug Class

Anticonvulsant


Therapeutic Actions

Mechanism of action not fully understood; inhibits voltage-sensitive sodium and calcium channels, stabilizing the neuronal membrane and modulating calcium-dependent presynaptic release of excitatory amino acids; may also have dopaminergic effects.


Indications



  • Adjuvant therapy in the treatment of partial seizures in adults with epilepsy



Available Forms

Capsules—25, 50, 100 mg


Dosages

Adults

Initial dose, 100 mg PO daily as a single dose—not divided—subsequent doses can be divided; may increase by 100 mg/day every 2 wk to achieve control.

Pediatric patients

Not recommended in patients younger than 16 yr.

Patients with renal impairment

Do not use in patients with a glomerular filtration rate of less than 50 mL/min.

Jul 21, 2016 | Posted by in NURSING | Comments Off on Zonisamide

Full access? Get Clinical Tree

Get Clinical Tree app for offline access